Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
NCT03096418Phase 4Recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- Mar 2017
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Paclitaxel Micelles for Injection in breast cancer, sponsored by University of Wisconsin–Madison. Started Mar 2017; status: recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03096418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096418.